Genesis Global Group

You will now be redirected to the GD3 website

PharmOptima is a proud member of Genesis Drug Discovery & Development (GD3), a fully integrated CRO providing services to support drug discovery programs of our clients from target discovery through IND filing and managing Phase I-III clinical trials.

Learn more about GD3


Your compounds can be tested in PharmOptima’s vivarium for in vivo bioavailability, metabolism, pharmacologic efficacy, and tolerance.

What we can do for you:

  • extensive ophthalmic expertise
  • transgenic mouse colony capabilities
  • evaluation of drug tolerance, integration of studies with drug delivery and pharmacokinetics (PK)

Routes of Administration

  • Oral Gavage
  • Subcutaneous
  • Intravenous/Infusion
  • Intact Spinal Cord Collection
  • Intraperitoneal
  • Intramuscular
  • Intravitreal
  • Topical (Ocular)
  • Dermal
  • Intratracheal
  • Intranasal Inhalation/Instillation
  • Intrathecal

Ocular Tissue Collection


  • Aqueous humor, Cornea, Conjunctiva (palpebral and/or bulbar)
  • Meibomian Glands
  • Trabecular meshwork, Iris-Ciliary body, Lens


  • Vitreous humor, Optic Nerve
  • Sclera, Choroid (central and/or peripheral)
  • Retina (central and/or peripheral)
Hand Holding a Mouse